Evidence map›Paper›PMID 29239118›Full record

ArticleZoonoses and public health2018

Zoonotic origin and transmission of Middle East respiratory syndrome coronavirus in the UAE.

C R Paden, M F B M Yusof, Z M Al Hammadi, K Queen, Y Tao, Y M Eltahir, E A Elsayed, B A Marzoug, O K A Bensalah, A I Khalafalla and 19 more

Registry-linked trialAbstract read
In one paragraph

Article in Zoonoses and public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04420260 (Scheme of Primary Prevention of Infection by COVID-19, in Workers), which is not on this map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04420260 nacompletednot on this mapstarted 2021, after this paper: background citation

Scheme of Primary Prevention of Infection by COVID-19, in Workers: Phase II Controlled Clinical Trial, to be Carried Out in Medellín-Antioquia

TypeinterventionalSponsorUnidad de Investigación Genética MolecularRan2021 to 2021Enrolled152ConditionsCOVIDArmsGroup A: oropharygeal spray and immunostimulant emulsion, Group D:Placebo oropharyngeal spray + Placebo taken PO
3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. An Overview on the Zoonotic Aspects of COVID-19.Proceedings of the National Academy of Sciences, India. Section B · 2023
    Review
  6. Zoonotic diseases transmitted from the camels.Frontiers in veterinary science · 2023
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Natural product remedies for COVID-19: A focus on safety.South African journal of botany : official journal of the South African Association of Botanists = Suid-Afrikaanse tydskrif vir plantkunde : amptelike tydskrif van die Suid-Afrikaanse Genootskap van Plantkundiges · 2021
    Review
  15. Review
  16. Article
  17. Review
  18. Coronaviruses - Potential human threat from foodborne transmission?Lebensmittel-Wissenschaft + [i.e. und] Technologie. Food science + technology. Science + technologie alimentaire · 2020
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

C R PadenDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0001-8701-8948
M F B M YusofAbu Dhabi Food Control Authority, Abu Dhabi, United Arab Emirates.
Z M Al HammadiAbu Dhabi Food Control Authority, Abu Dhabi, United Arab Emirates.
K QueenDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Y TaoDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Y M EltahirAbu Dhabi Food Control Authority, Abu Dhabi, United Arab Emirates.
E A ElsayedAbu Dhabi Food Control Authority, Abu Dhabi, United Arab Emirates.
B A MarzougAbu Dhabi Food Control Authority, Abu Dhabi, United Arab Emirates.
O K A BensalahAbu Dhabi Food Control Authority, Abu Dhabi, United Arab Emirates.
A I KhalafallaAbu Dhabi Food Control Authority, Abu Dhabi, United Arab Emirates.
M Al MullaHealth Authority Abu Dhabi, Abu Dhabi, United Arab Emirates.
A KhudhairHealth Authority Abu Dhabi, Abu Dhabi, United Arab Emirates.
K A ElkheirHealth Authority Abu Dhabi, Abu Dhabi, United Arab Emirates.
Z B IssaHealth Authority Abu Dhabi, Abu Dhabi, United Arab Emirates.
K PradeepHealth Authority Abu Dhabi, Abu Dhabi, United Arab Emirates.
F N ElsalehHealth Authority Abu Dhabi, Abu Dhabi, United Arab Emirates.
H ImambaccusSheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
J SasseSheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
S WeberSheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
M ShiThe University of Sydney, Sydney, NSW, Australia.
J ZhangDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Y LiDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
H PhamDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
L KimDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
A J HallDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
S I GerberDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
F I Al HosaniHealth Authority Abu Dhabi, Abu Dhabi, United Arab Emirates.
S TongDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
S S M Al MuhairiAbu Dhabi Food Control Authority, Abu Dhabi, United Arab Emirates.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Since the emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, there have been a number of clusters of human-to-human transmission. These cases of human-to-human transmission involve close contact and have occurred primarily in healthcare settings, and they are suspected to result from repeated zoonotic introductions. In this study, we sequenced whole MERS-CoV genomes directly from respiratory samples collected from 23 confirmed MERS cases in the United Arab Emirates (UAE). These samples included cases from three nosocomial and three household clusters. The sequences were analysed for changes and relatedness with regard to the collected epidemiological data and other available MERS-CoV genomic data. Sequence analysis supports the epidemiological data within the clusters, and further, suggests that these clusters emerged independently. To understand how and when these clusters emerged, respiratory samples were taken from dromedary camels, a known host of MERS-CoV, in the same geographic regions as the human clusters. Middle East respiratory syndrome coronavirus genomes from six virus-positive animals were sequenced, and these genomes were nearly identical to those found in human patients from corresponding regions. These data demonstrate a genetic link for each of these clusters to a camel and support the hypothesis that human MERS-CoV diversity results from multiple zoonotic introductions.

Indexed as

AnimalsCamelusCoronavirus InfectionsGenome, ViralHumansMiddle East Respiratory Syndrome CoronavirusPhylogenyUnited Arab EmiratesZoonosesdromedary camelepidemiologygenomicsmiddle east respiratory syndromeviral pathogenszoonoses

Identifiers

PMID29239118
PMCPMC5893383

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.